WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Sitting Tai Chi Exercises Help Improve Stroke Recovery: StudyFeature: Smart atChina Has 570,000 Public Legal Service Centers: Ministry'Drifters' Bring New Vitality to Ancient Xinjiang CityChina Unveils Plan to Boost Healthcare for Women, ChildrenChina Implements Differentiated Epidemic Control Measures in Factories to Keep Production StableWondrous Xinjiang: Winter Sports Fever Boosts IcePeople participate in MalaysiaChina's CollegeChina Rolls out Five